University Of Patras
- Address
- lock Available on a paid plan
University Of Patras - Rare Hematological Disorders Research
The University of Patras is actively engaged in advanced clinical research focusing on rare and complex hematological conditions. The center has established expertise in evaluating novel therapeutic approaches for patients with challenging blood disorders, particularly those who have not achieved optimal treatment outcomes with existing therapies.
- Paroxysmal nocturnal hemoglobinuria (PNH) and complement-mediated disorders
- Pharmacokinetics and pharmacodynamics studies of innovative biologics
- Treatment optimization for patients with sub-optimal responses to complement inhibitors
The research center demonstrates specialized capability in conducting proof-of-concept studies for emerging therapies in rare hematological diseases. Their work includes comprehensive evaluation of safety, tolerability, and preliminary efficacy of novel agents, with particular emphasis on addressing unmet medical needs in patients with complement system disorders who require alternative or enhanced therapeutic strategies.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Of Patras
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients with Sub-optimal Response to C5 Inhibitor Ravulizumab: A Phase 2 Study | Omeros Corp., Omeros Ireland Limited | Phase I | Not Recruiting | May 2023 | Oct 2024 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.